Symbols / PPCB Stock $0.10 +0.00% Propanc Biopharma, Inc.

Healthcare • Biotechnology • Australia • NCM
PPCB (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Mr. James Nathanielsz
Exch · Country NCM · Australia
Market Cap 2.22M
Enterprise Value 2.60M
Income -67.00M
Sales —
FCF (ttm) 14.25M
Book/sh 0.78
Cash/sh 0.04
Employees 1
Insider 10d —
IPO Jan 07, 2013
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 0.00
Forward P/E —
PEG —
P/S —
P/B 0.13
P/C —
EV/EBITDA -0.04
EV/Sales —
Quick Ratio 0.16
Current Ratio 2.13
Debt/Eq 5.67
LT Debt/Eq —
EPS (ttm) 52.11
EPS next Y —
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA -5.36%
ROE -18.12%
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 21.86M
Shs Float 10.83M
Insider Own 40.46%
Instit Own 0.62%
Short Float 1.27%
Short Ratio 0.03
Short Interest 201.71K
52W High 10.81
vs 52W High -99.06%
52W Low 0.10
vs 52W Low 6.95%
Beta 3.52
Impl. Vol. —
Rel Volume 0.04
Avg Volume 4.03M
Volume 174.47K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $0.10
Price $0.10
Change 0.00%
About

Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. Its lead product candidate is PRP, an intravenous injection proenzyme treatment designed as a therapeutic option in cancer treatment and prevention which has completed pre-clinical studies. The company has a research and collaboration agreement with the University of Jaén, to undertakes the research activities for the POP1 Program and the University of Granada to develop a synthetic recombinant version of PRP. Propanc Biopharma, Inc. was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. The company was incorporated in 2007 and is based in Camberwell, Australia.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.10
Latest analyst target
3. DCF / Fair value
$11.74
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.10
Low
—
High
—
Mean
—
News
RSS: Latest PPCB news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
57.28
+3628.93%
1.54
-13.54%
1.78
-10.76%
1.99
Research And Development
0.22
-9.83%
0.25
+0.07%
0.25
-3.18%
0.26
Selling General And Administration
57.05
+4329.87%
1.29
-15.75%
1.53
-11.88%
1.73
General And Administrative Expense
57.05
+4329.87%
1.29
-15.75%
1.53
-11.88%
1.73
Other Gand A
57.03
+4448.41%
1.25
-16.41%
1.50
-12.11%
1.71
Total Expenses
57.28
+3628.93%
1.54
-13.54%
1.78
-10.76%
1.99
Operating Income
-57.28
-3628.93%
-1.54
+13.54%
-1.78
+10.76%
-1.99
Total Operating Income As Reported
-57.28
-3628.93%
-1.54
+13.54%
-1.78
+10.76%
-1.99
EBITDA
-58.34
-4522.17%
-1.26
+43.52%
-2.23
-4.49%
-2.14
Normalized EBITDA
-57.26
-3681.07%
-1.51
+13.65%
-1.75
+11.41%
-1.98
Reconciled Depreciation
0.02
-6.78%
0.02
-5.56%
0.02
+304.36%
0.01
EBIT
-58.36
-4445.78%
-1.28
+43.13%
-2.26
-5.28%
-2.14
Total Unusual Items
-1.08
-528.85%
0.25
+152.43%
-0.48
-202.48%
-0.16
Total Unusual Items Excluding Goodwill
-1.08
-528.85%
0.25
+152.43%
-0.48
-202.48%
-0.16
Special Income Charges
-0.87
-1696.32%
0.05
+25.53%
0.04
+348.35%
-0.02
Other Special Charges
0.87
+1696.32%
-0.05
-25.53%
-0.04
-348.35%
0.02
Net Income
-58.92
-3136.60%
-1.82
+31.57%
-2.66
-0.09%
-2.66
Pretax Income
-58.92
-2922.23%
-1.95
+30.13%
-2.79
-2.85%
-2.71
Net Non Operating Interest Income Expense
-0.56
+15.33%
-0.67
-24.96%
-0.53
+5.40%
-0.56
Interest Expense Non Operating
0.56
-15.33%
0.67
+24.97%
0.53
-6.33%
0.57
Net Interest Income
-0.56
+15.33%
-0.67
-24.96%
-0.53
+5.40%
-0.56
Interest Expense
0.56
-15.33%
0.67
+24.97%
0.53
-6.33%
0.57
Interest Income Non Operating
0.00
-85.00%
0.00
+66.67%
0.00
-99.36%
0.01
Interest Income
0.00
-85.00%
0.00
+66.67%
0.00
-99.36%
0.01
Other Income Expense
-1.08
-528.85%
0.25
+152.43%
-0.48
-202.48%
-0.16
Gain On Sale Of Security
-0.21
-206.47%
0.20
+137.68%
-0.52
-270.62%
-0.14
Tax Provision
0.00
+100.00%
-0.13
+0.55%
-0.13
-136.17%
-0.05
Tax Rate For Calcs
0.00
0.00
-100.00%
0.00
+129.62%
0.00
Tax Effect Of Unusual Items
0.00
0.00
+100.00%
-0.02
-594.59%
-0.00
Net Income Including Noncontrolling Interests
-58.92
-3136.60%
-1.82
+31.57%
-2.66
-0.09%
-2.66
Net Income From Continuing Operation Net Minority Interest
-58.92
-3136.60%
-1.82
+31.57%
-2.66
-0.09%
-2.66
Net Income From Continuing And Discontinued Operation
-58.92
-3136.60%
-1.82
+31.57%
-2.66
-0.09%
-2.66
Net Income Continuous Operations
-58.92
-3136.60%
-1.82
+31.57%
-2.66
-0.09%
-2.66
Normalized Income
-57.84
-2690.66%
-2.07
+5.87%
-2.20
+12.00%
-2.50
Net Income Common Stockholders
-58.92
-2826.43%
-2.01
+35.61%
-3.13
+6.90%
-3.36
Otherunder Preferred Stock Dividend
0.00
-100.00%
0.19
-58.62%
0.47
-33.42%
0.70
Diluted EPS
-14.85
+98.95%
-1,420.53
+95.46%
-31,268.39
+97.21%
-1,119,475.67
Basic EPS
-14.85
+98.95%
-1,420.53
+95.46%
-31,268.39
+97.21%
-1,119,475.67
Basic Average Shares
3.97
+279940.65%
0.00
+1317.00%
0.00
+3233.33%
0.00
Diluted Average Shares
3.97
+279940.65%
0.00
+1317.00%
0.00
+3233.33%
0.00
Diluted NI Availto Com Stockholders
-58.92
-2826.43%
-2.01
+35.61%
-3.13
+6.90%
-3.36
Rent And Landing Fees
0.03
-22.23%
0.03
+18.41%
0.03
+1.67%
0.03
Rent Expense Supplemental
0.03
-22.23%
0.03
+18.41%
0.03
+1.67%
0.03
Line Item Trend 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total Assets
0.07
+19.95%
0.06
-26.11%
0.08
—
Current Assets
0.03
+33.63%
0.02
+26.67%
0.02
—
Cash Cash Equivalents And Short Term Investments
0.02
+109.86%
0.01
+147.04%
0.00
—
Cash And Cash Equivalents
0.02
+109.86%
0.01
+147.04%
0.00
—
Cash Financial
0.02
+109.86%
0.01
+147.04%
0.00
—
Receivables
0.00
+2.90%
0.00
+22.42%
0.00
—
Taxes Receivable
0.00
+2.90%
0.00
+22.42%
0.00
—
Prepaid Assets
0.00
-100.00%
0.01
-28.95%
0.01
—
Other Current Assets
0.00
-77.04%
0.01
-28.95%
0.01
—
Total Non Current Assets
0.05
+13.65%
0.04
-38.02%
0.07
—
Net PPE
0.02
-54.70%
0.04
-39.13%
0.06
—
Gross PPE
0.09
+0.12%
0.09
-3.37%
0.09
—
Accumulated Depreciation
-0.07
-41.27%
-0.05
-72.87%
-0.03
—
Properties
0.00
0.00
0.00
—
Buildings And Improvements
0.07
+0.00%
0.07
+0.00%
0.07
—
Machinery Furniture Equipment
0.03
+0.44%
0.03
-11.15%
0.03
—
Non Current Deferred Assets
0.03
0.00
—
—
Non Current Prepaid Assets
0.00
+0.45%
0.00
-3.66%
0.00
—
Total Liabilities Net Minority Interest
3.85
+21.21%
3.18
+2.33%
3.11
—
Current Liabilities
3.79
+20.09%
3.16
+3.11%
3.06
—
Payables And Accrued Expenses
2.13
+31.41%
1.62
+8.22%
1.50
—
Payables
1.24
+24.77%
1.00
+2.32%
0.97
—
Accounts Payable
1.21
+25.51%
0.97
+2.51%
0.94
—
Current Accrued Expenses
0.89
+42.02%
0.62
+19.18%
0.52
—
Pensionand Other Post Retirement Benefit Plans Current
0.64
+8.81%
0.59
+41.32%
0.42
—
Current Debt And Capital Lease Obligation
0.89
+68.93%
0.53
-47.24%
1.00
—
Current Debt
0.87
+72.28%
0.51
-48.33%
0.98
—
Other Current Borrowings
0.67
+31.76%
0.51
-48.33%
0.98
—
Current Capital Lease Obligation
0.02
-9.97%
0.02
+4.37%
0.02
—
Other Current Liabilities
0.13
-68.36%
0.42
+179.79%
0.15
—
Total Non Current Liabilities Net Minority Interest
0.06
+204.19%
0.02
-54.45%
0.04
—
Long Term Debt And Capital Lease Obligation
0.06
+204.19%
0.02
-54.45%
0.04
—
Long Term Debt
0.06
—
—
—
Long Term Capital Lease Obligation
0.00
-100.00%
0.02
-54.45%
0.04
—
Stockholders Equity
-3.78
-21.23%
-3.12
-3.09%
-3.02
—
Common Stock Equity
-3.78
-21.23%
-3.12
-2.92%
-3.03
—
Capital Stock
0.00
-99.90%
0.01
+46.03%
0.01
—
Common Stock
0.00
-99.90%
0.01
+3088.33%
0.00
—
Preferred Stock
0.00
0.00
-100.00%
0.01
—
Share Issued
0.01
+7880.00%
0.00
+3233.33%
0.00
—
Ordinary Shares Number
0.01
+7880.00%
0.00
+3233.33%
0.00
—
Treasury Shares Number
0.00
0.00
0.00
0.00
Additional Paid In Capital
61.70
+2.30%
60.31
+5.14%
57.36
—
Retained Earnings
-66.70
-3.11%
-64.68
-5.08%
-61.56
—
Gains Losses Not Affecting Retained Earnings
1.27
-1.95%
1.29
+4.89%
1.23
—
Treasury Stock
0.05
+0.00%
0.05
+0.00%
0.05
—
Other Equity Adjustments
1.27
-1.95%
1.29
+4.89%
1.23
—
Total Equity Gross Minority Interest
-3.78
-21.23%
-3.12
-3.09%
-3.02
—
Total Capitalization
-3.72
-19.35%
-3.12
-3.09%
-3.02
—
Working Capital
-3.77
-20.01%
-3.14
-2.99%
-3.05
—
Invested Capital
-2.85
-9.12%
-2.61
-27.35%
-2.05
—
Total Debt
0.95
+73.70%
0.55
-47.53%
1.04
—
Net Debt
0.91
+83.37%
0.50
-49.15%
0.97
—
Capital Lease Obligations
0.02
-52.52%
0.04
-35.19%
0.06
—
Net Tangible Assets
-3.78
-21.23%
-3.12
-3.09%
-3.02
—
Tangible Book Value
-3.78
-21.23%
-3.12
-2.92%
-3.03
—
Current Notes Payable
0.20
0.00
—
—
Dueto Related Parties Current
0.03
+0.44%
0.03
-3.63%
0.03
—
Interest Payable
0.09
+111.62%
0.04
-22.68%
0.06
—
Other Equity Interest
—
—
-0.02
—
Preferred Shares Number
—
—
0.50
+0.00%
0.50
Preferred Stock Equity
—
—
0.01
+0.00%
0.01
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Operating Cash Flow
-0.41
+56.67%
-0.94
+15.39%
-1.11
+23.05%
-1.44
Cash Flow From Continuing Operating Activities
-0.41
+56.67%
-0.94
+15.39%
-1.11
+23.05%
-1.44
Net Income From Continuing Operations
-58.92
-3136.60%
-1.82
+31.57%
-2.66
-0.09%
-2.66
Depreciation Amortization Depletion
0.02
-6.78%
0.02
-5.56%
0.02
+304.36%
0.01
Depreciation
0.02
-6.78%
0.02
-5.56%
0.02
+304.36%
0.01
Depreciation And Amortization
0.02
-6.78%
0.02
-5.56%
0.02
+304.36%
0.01
Other Non Cash Items
51.66
+17244.08%
0.30
-8.71%
0.33
-10.58%
0.36
Stock Based Compensation
4.62
0.00
—
—
Provisionand Write Offof Assets
0.00
-100.00%
0.12
0.00
—
Operating Gains Losses
1.08
+3826.59%
0.03
-96.25%
0.73
+7.27%
0.68
Gain Loss On Investment Securities
0.12
+16.28%
0.10
-86.39%
0.77
+22.68%
0.62
Net Foreign Currency Exchange Gain Loss
0.09
+504.18%
-0.02
-275.19%
-0.01
-113.88%
0.04
Change In Working Capital
1.14
+172.68%
0.42
-11.67%
0.47
+182.25%
0.17
Change In Receivables
-0.00
-3287.32%
-0.00
+88.36%
-0.00
-136.75%
0.00
Change In Prepaid Assets
0.00
+101.19%
-0.12
-5425.94%
0.00
+125.31%
-0.01
Change In Payables And Accrued Expense
1.12
+111.03%
0.53
+74.73%
0.30
+105.71%
0.15
Change In Accrued Expense
0.93
+223.19%
0.29
+29.47%
0.22
+73.00%
0.13
Change In Payable
0.19
-22.56%
0.24
+199.36%
0.08
+329.12%
0.02
Change In Account Payable
0.19
-22.56%
0.24
+199.36%
0.08
+329.12%
0.02
Change In Other Working Capital
0.04
+66.08%
0.02
-87.05%
0.19
+524.98%
0.03
Change In Other Current Liabilities
-0.02
-0.57%
-0.02
-8.77%
-0.02
-505.95%
-0.00
Financing Cash Flow
0.49
-47.90%
0.94
-15.43%
1.11
-25.29%
1.49
Cash Flow From Continuing Financing Activities
0.49
-47.90%
0.94
-15.43%
1.11
-25.29%
1.49
Net Issuance Payments Of Debt
0.76
-17.79%
0.92
+55.67%
0.59
-22.99%
0.77
Issuance Of Debt
0.89
-16.53%
1.06
+79.88%
0.59
-22.99%
0.77
Repayment Of Debt
-0.13
+8.48%
-0.14
0.00
0.00
Long Term Debt Issuance
0.34
+12.80%
0.30
0.00
-100.00%
0.77
Long Term Debt Payments
—
—
—
0.00
Net Long Term Debt Issuance
0.34
+12.80%
0.30
0.00
-100.00%
0.77
Short Term Debt Issuance
0.54
-28.34%
0.76
+28.26%
0.59
-22.99%
0.77
Short Term Debt Payments
-0.13
+8.48%
-0.14
0.00
—
Net Short Term Debt Issuance
0.41
-32.96%
0.61
+4.05%
0.59
-22.99%
0.77
Net Common Stock Issuance
0.00
-100.00%
0.02
-6.69%
0.02
-75.11%
0.10
Proceeds From Stock Option Exercised
—
0.00
-100.00%
0.47
-24.00%
0.63
Net Other Financing Charges
-0.26
—
0.02
—
Changes In Cash
0.09
+1163.11%
0.01
-19.98%
0.01
-84.46%
0.05
Effect Of Exchange Rate Changes
-0.09
-2319.26%
0.00
+271.30%
-0.00
+95.28%
-0.05
Beginning Cash Position
0.02
+109.86%
0.01
+147.04%
0.00
+80.35%
0.00
End Cash Position
0.01
-42.67%
0.02
+109.86%
0.01
+147.04%
0.00
Free Cash Flow
-0.41
+56.67%
-0.94
+15.39%
-1.11
+23.05%
-1.44
Interest Paid Supplemental Data
0.03
+223.62%
0.01
+229.21%
0.00
+20.53%
0.00
Income Tax Paid Supplemental Data
0.00
0.00
0.00
0.00
Amortization Of Securities
—
—
—
0.45
Change In Interest Payable
0.26
+224.08%
0.08
-14.86%
0.09
+44.77%
0.06
Common Stock Issuance
0.00
-100.00%
0.02
-6.69%
0.02
-75.11%
0.10
Issuance Of Capital Stock
0.00
-100.00%
0.02
-6.69%
0.02
-75.11%
0.10
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category